View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Ophthalmic Business News

SPONSORED CONTENT
Save
SPONSORED CONTENT
March 05, 2024
1 min read
Save

Clobetasol propionate ophthalmic suspension 0.05% approved for postop inflammation, pain

Clobetasol propionate ophthalmic suspension 0.05% approved for postop inflammation, pain

The FDA approved clobetasol propionate ophthalmic suspension 0.05% for the treatment of inflammation and pain after ocular surgery, according to a press release from Formosa Pharmaceuticals and AimMax Therapeutics.

SPONSORED CONTENT
March 04, 2024
1 min read
Save

Sandoz completes acquisition of ranibizumab biosimilar

Sandoz completes acquisition of ranibizumab biosimilar

Sandoz has completed the acquisition of Cimerli, a ranibizumab biosimilar, from Coherus BioSciences, according to a press release.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
March 01, 2024
4 min read
Save

Retirement planning involves three long-term keys to success

Retirement planning involves three long-term keys to success

The number one financial goal for most doctors is, by far, getting to a comfortable retirement on their own timeline and with the lifestyle they want.

SPONSORED CONTENT
February 29, 2024
1 min read
Save

PulseSight Therapeutics launches with focus on non-viral gene therapies

PulseSight Therapeutics launches with focus on non-viral gene therapies

PulseSight Therapeutics, which is developing non-viral gene therapies for retinal diseases, has launched with seed financing from Pureos Bioventures and ND Capital, according to a press release.

SPONSORED CONTENT
February 28, 2024
1 min read
Save

Leadership changes strengthen Ocular Therapeutix’s focus on retina care

Leadership changes strengthen Ocular Therapeutix’s focus on retina care

Ocular Therapeutix announced changes to its leadership and board of directors to strengthen its focus on retina care.

SPONSORED CONTENT
February 25, 2024
3 min watch
Save

VIDEO: Verséa offers amniotic membrane graft, point-of-care testing platform

VIDEO: Verséa offers amniotic membrane graft, point-of-care testing platform

WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Rahim Hirji, RPh, describes the products available from Verséa Ophthalmics.

SPONSORED CONTENT
February 23, 2024
49 min listen
Save

Live from Hawaiian Eye 2024

Live from Hawaiian Eye 2024

John A. Hovanesian, MD, FACS, and Jim Mazzo sit down with guests Eric D. Donnenfeld, MD, Calvin C. Roberts, MD, Mark L. Baum and Jeannette Bankes to discuss private equity, industry breakthroughs and more.

SPONSORED CONTENT
February 23, 2024
1 min read
Save

Opthea appoints Arshad M. Khanani as chief medical advisor

Opthea appoints Arshad M. Khanani as chief medical advisor

Arshad M. Khanani, MD, MA, FASRS, a renowned retina specialist and clinical researcher, has been appointed as chief medical advisor of Opthea Limited, according to a press release.

SPONSORED CONTENT
February 22, 2024
2 min watch
Save

VIDEO: Office-based surgery holds potential but faces financial, legislative challenges

VIDEO: Office-based surgery holds potential but faces financial, legislative challenges

TAMPA, Fla. — In this Healio Video Perspective from Telling It Like It Is, Kendall E. Donaldson, MD, MS, discusses the benefits of office-based surgery while highlighting some of its obstacles.

SPONSORED CONTENT
February 19, 2024
1 min read
Save

Harrow licenses 5 ophthalmic products to Canada-based Apotex

Harrow licenses 5 ophthalmic products to Canada-based Apotex

Harrow has announced an exclusive out-licensing agreement with Apotex, a major Canadian pharmaceutical company, to market and distribute five of the company’s branded ophthalmic products.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails